Metoceolate drops
Recall
|
Medicines
|
29/04/2014
The marketing authorization holder informed its supplied customers by letter dated April 28, 2014, that due to the implementing decision C (2013)9846 in the context of the European risk assessment procedure according to Article 31 of Directive 2011/83/EC, the marketing authorization for "Metoceolate 4 mg/ml - Drops" will be revoked as of April 30, 2014.04.2014 is revoked, as it is a liquid formulation for oral use with a concentration of more than 1mg/ml of the active substance metoclopramide. Accordingly, the product may no longer be marketed in Austria at this time and thus a recall has been initiated.
| Name of the medicinal product | Metoceolat 4 mg/ml –Tropfen (Bezeichnung vor dem 05.12.2012 Metoclopramid Ceolat 4 mg/ml – Tropfen) |
|---|---|
| Marketing authorisation number(s) | 1-31681 |
| Marketing authorisation holder | G.L. Pharma GmbH |
| Batch number(s) | 3E611A, 4B609A (Metoceolat 4 mg/ml – Tropfen) 2M633A (Metoclopramid Ceolat 4 mg/ml – Tropfen) |
| Classification of the recall | 3 |
| BASG reference number | INS - 640.001 - 1094 |
Further inquiry note
Page last modified:
12/07/2022